MSD Animal Health Receives Positive Opinion from CVMP for NOBIVAC® L6 and NOBIVAC® LoVo L6 Vaccines for Use in Dogs Against Leptospirosis
Rahway, NJ., June 12, 2025 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for the NOBIVAC® L6 and NOBIVAC® LoVo L6 vaccines. If the European Commission (EC) adopts the recommendation, the […]